The Toronto Transplant & HPB Fellows 2018-2019
Left to Right: Drs. Ashley Limkemann, Sanju Sobnach, Graziano Oldani, Blayne A. Sayed, Lawrence Lau, Christopher Shubert, and Robin Visser
Welcome to our Fellowship Programs. The University of Toronto has a legacy for being at the forefront of research, innovation, and education in the fields of transplantation and hepatopancreatobiliary (HPB) surgery. Our respective programs are among the largest in North America based on clinical volumes, and we have a proud history of training many of the leaders in surgery over the last 37 years. We offer both an AHPBA-accredited HPB surgical oncology track and a combined ASTS-accredited abdominal transplantation surgery track.
As junior fellows, all trainees are immersed in both disciplines gaining a unique hybrid, high volume experience. As second year fellows, trainees become more focused gaining in-depth exposure within their respective clinical track. They are afforded opportunities to participate in complex HPB and minimally-invasive surgery, and to be a part of one of the largest pediatric transplantation and living donor liver transplant programs in North America. In addition to an outstanding operative experience, the fellow’s knowledge is further enhanced through participation in a robust academic curriculum of teaching seminars and by in-depth training in the pre- and postoperative management of these complex patients in both the inpatient and outpatient settings.
We also offer a multitude of opportunities to participate in both clinical and basic science research with many of our investigators being world leaders in their respective fields. We are proud to continue our legacy of training the future generation of academic transplant/HPB surgeons. We invite you to further explore our website and see how our program may enhance your training and in turn help shape the future of transplantation, HPB surgery, and cancer care.
During the first year, the Transplant and HPB Fellowships are integrated. The ASTS required case volume are exceeded through:
- Pediatric, small intestinal and multivisceral transplant
- Laparoscopic Living Donor Nephrectomy (40+ per year)
- Pre-op planning & Volumetric measurements using Myrian workstations
- Donation after Neurologic & Cardiocirculatory Death
- Vascular access
- Transplant Clinics
The second year focuses on complex transplant procedures: re-transplants, Living Donors & Transplants, split-liver, multiviscerals, and pediatric transplants.
During the first year, the ASTS & AHPBA required case volumes are exceeded through:
- 6-8 elective HPB ORs per week (with 10 Transplant & HPB Surgeons)
- 150+ liver resections, 100+ pancreaticoduodenectomies, 80% oncology
- Laparoscopic HPB Surgery
- 3-month assignments with HBP & Transplant surgeons and Surgical Oncology Clinics
The Fellowship program offers multiple opportunities for additional learning through:
- Fellowship Exchange Program (for Fellows in their second year)
- Transplant and HPB Seminar Series
- Transplant Conferences: Live Donor, Listing, and Quality
- Multi-Organ Transplant Rounds & Invited Professors
- Journal Clubs (offered for both HPB and Transplant)
- HBP Conference, Hepatoma Review Board, Surgical Oncology Tumor Board
For Clinical and Outcomes Research, Fellows can expect one project in the first year, and multiple projects in their second year of study.
There will be Basic Science opportunities for laboratory-based research on the topics of:
- Dendritic cells
- Stem cell biology
Research in education is also offered.
Fellows will experience the advantages of a “large” Fellowship program with 7 to 8 Transplant and HPB Fellows:
- On-call scheduling and cross-coverage
- Facilitates time off without compromising clinical experience
News & Announcements
Dr. Markus Selzner, Surgical Director of the Liver Transplant Program at the University Health Network, is the course director for the first ILTS Organ Profusion Workshop taking place tomorrow at Toronto General Hospital. The course includes lectures on Cold...read more
Surgeons at Toronto General Hospital have begun a research study to determine if living donor liver transplantation is an effective treatment for colorectal cancer which has spread to the liver. The first patient in this study, who has chosen to remain anonymous,...read more
Four pillars of the UHN Transplant community were bid a heartfelt farewell by colleagues, luminaries and staff as they retire within the next month and begin new lives exploring everything from cottage life to the science of happiness to playing in a blues-rock band....read more